OREANDA-NEWS. According to the results of the year 2013 total sales of the top five best selling Rx drugs amounted to RUR 1,639.1 million, which corresponds to 44.0% of sales in the Rx drugs segment and 31.1%[1] of the Company's total sales.

According to the results of the year 2013 the top five best selling Rx drugs are:

Geptor (Ademetionine; ATC[2] "Digestive tract and metabolism"); sales increased by 20.6% as compared to the same period of the previous year; 14.9% of sales in the Rx drugs segment;

Cerepro (Choline Alfoscerate; ATC "Medications for the treatment of the nervous system diseases"); sales in the segment made 9.6%;

Tautax (Docetaxel; ATC "Antineoplastic and immunomodulating agents"); sales in the segment made 9.5%;

Irunine (Itraconazole; ATC "Antimicrobials for systematic use"); sales in the segment made 5.0%;

Parclitaxel-LENS (Parclitaxel; ATC "Antineoplastic and immunomodulating agents"); sales in the segment made 4.9%;

OTC drugs

OTC drugs segment is characterized by the high degree of consolidation. It means that the top five best selling medicines make 98.4% of sales.

Xilen (Xylometazoline; ATC "Medications for the treatment of respiratory system"); sales in the OTC drugs segment made 49.1%;

Slabilen (Sodium picosulfate; ATC "Alimentary tract and metabolism"); sales in the OTC drugs segment made 30.0%;

Motilak (Domperidone; ATC "Alimentary tract and metabolism"); sales in the OTC drugs segment made 15.3%;

Vitasharm and Vitatress (ATC "Vitamins"); sales in the OTC drugs segment made 3.2%;

Ginkgo biloba (Ginkgo biloba; ATC "Medications for the treatment of urogenital organs"); sales in the OTC drugs segment made 0.8%.

Traditional drugs segment

According to the results of 2013 the top five best selling traditional drugs are:

Vero-Dexamethasone (Dexamethasone; ATC "Hormonal drugs for systematic use"); sales in the traditional drugs segment made 39.7%;

Pyridoxine (ATC "Alimentary tract and metabolism"); sales in the segment made 27.6%;

Vero-Ciprofloxacin (Ciprofloxacin; ATC "Antimicrobials for systematic use"); sales in the segment made 12.4%;

Vero-Loperamide (Loperamide; ATC "Alimentary tract and metabolism"); sales in the segment made 12.0%;

Vero-Flukonazole (Fluconazole; ATC "Antimicrobials for systematic use"); sales in the segment made 4.4%;

Non-pharamaceutical products

According to the results of 2013 the top five best selling non-pharamaceutical products are:

Conventional antimicrobial adhesive bandages; 36.8% of sales in the segment;

Conventional reel adhesive bandages; 23.2% of sales in the segment;

Therapeutic patches - pepper plasters; 20.0% of sales in the segment;

Therapeutic patches - corn plasters; 15.4% of sales in the segment;

Comida (ATC “Nutritional therapy”); 2.4% of sales in the segment.

NEW DRUGS PRODUCTION AND SALES

During 2013 Veropharm initiated production and sales of new forms and dosages of the following drugs:

Anfibra (Enoxaparin sodium; ATC "Medications affecting hematogenesis and blood");

Salbutamol (Salbutamol; ATC "Medications for the treatment of respiratory system");

ACP (Escitolapram, ATC "Medications for the treatment of the nervous system diseases");

Gistamel (Imatinib; ATC "Antineoplastic and immunomodulating agents");

Vero-Ifosfamide (Ifosfamide; ATC "Antineoplastic and immunomodulating agents");

Iriten (Irinotecan; ATC "Antineoplastic and immunomodulating agents");

Mielastra (Filgrastim; ATC "Antineoplastic and immunomodulating agents");

Bereta (Rabeprazole; ATC "Alimentary tract and metabolism");

Motilak (Domperidone; ATC "Alimentary tract and metabolism");

GeptorDaily (Ademetionine; ATC "Alimentary tract and metabolism");

Timolol-LENS (Timolol; ATC “Medications for the sense organs treatment”);

Vero-Stavudine (Stavudine; ATC "Antimicrobials for systematic use");

Betaver (Betahistine; ATC “Medications for the treatment of nervous system”);

Poludan (Polyadenilic acid + Polyuridilic acid; ATC “Medications for the sense organs treatment”).

During 2013 Veropharm has initiated the sales of new forms of the following non-pharmaceutical products:

"Sensex" (Condoms; ATC "Medical items");

Sticking plaster “Uniplast” (ATC "Medical items");

Sticking plaster “Veroplast” (ATC "Medical items").

NEW DRUGS REGISTRATION

In the year 2013 Veropharm received registration for the following 3 drugs:

ACP (Escitolapram, ATC "Medications for the treatment of the nervous system diseases");

Gistamel (Imatinib; ATC " Antineoplastic and immunomodulating agents");

Bixicam (Meloxicam; ATC “Medications for the treatment of the muscularskeletal system diseases”).

In the year 2013 the following two substances were included in the State register of medicines and medical products:

Carboplatin produced by LLC “LENS-Pharm”;

Tropisetron hydrochloride produced by QUILU Pharmaceutical Co. Ltd., China.

In the year 2013 the following non-pharmaceutical products were registered:

Detoksiver - dietary supplement;

14 dietary products for weight control “Nutrico Diet®”;

9 perfume and cosmetic products.

NEW DRUGS REGISTRATION IN CIS COUNTRIES

In the year 2013 the following 3 drugs produced by LLC “LENS-Pharm” were registered in CIS countries:

Geptaver, lyophilizate for preparation of a solution for intravenous and intramuscular injection 400 mg in the Republic of Belarus (ATC "Alimentary tract and metabolism");

CONTRILENS, lyophilizate for preparation of a solution for intravenous injection 10 000 antitrypsin in the Republic of Uzbekistan (proteolysis inhibitor);

Vero-Methotrexat, solution for injections 5 mg/ml, 10 mg/ml in the Republic of Uzbekistan (ATC “Oncology drug, antimetabolite”).

[1] % - percent of finished goods sales

[2] ATC - anatomico-therapeutico-chemical group